Assessment of systemic inflammatory response index and other inflammatory indicators in retinal vein occlusion

Mehmet Bariş Üçer,Selim Cevher
DOI: https://doi.org/10.1097/md.0000000000036512
IF: 1.6
2024-02-23
Medicine
Abstract:Retinal vein occlusion (RVO) is the second most common retinal vascular disease after diabetic retinopathy. It causes visual dysfunction and vision loss due to complications such as macular edema, retinal ischemia, vitreous hemorrhage, and neovascularization. The prevalence of RVO is 0.42% for branch RVO (BRVO), 0.085 for central RVO (CRVO), and 0.52% for any RVO. Prevalence may vary by race and ethnicity, at a rate of 3.7 in whites, 5.7 in Asians, 3.9 in blacks, and 6.9 in Hispanics per 1000 individuals. It is estimated that around 16.4 (95% CI: 13.9–18.9) million people worldwide suffer from some type of RVO in at least 1 eye. [ 1 ] Several systemic and ocular risk factors, such as older age, systemic hypertension (HT), diabetes mellitus (DM), dyslipidemia, stroke, cerebrovascular event, chronic kidney disease, cardiovascular disease, atherosclerotic diseases, hypercoagulable situation, thrombophilia, oral contraceptives, smoking, systemic inflammatory diseases, glaucoma, high intraocular pressure, and increased cup-to-disc ratio are associated with RVO development. [ 2–4 ] RVO pathogenesis is multifactorial and not completely understood. Still, it follows the principles of Virchow triad: compression of the vein by the atherosclerotic artery, injury of the vessel wall, and hypercoagulability.
medicine, general & internal
What problem does this paper attempt to address?